Sattar N - Search Results

1

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome.

Harborne L, Fleming R, Lyall H, Norman J, Sattar N. Harborne L, et al. Among authors: sattar n. Lancet. 2003 May 31;361(9372):1894-901. doi: 10.1016/S0140-6736(03)13493-9. Lancet. 2003. PMID: 12788588 Review.

2

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.

Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N. Fleming R, et al. Among authors: sattar n. J Clin Endocrinol Metab. 2002 Feb;87(2):569-74. doi: 10.1210/jcem.87.2.8261. J Clin Endocrinol Metab. 2002. PMID: 11836287 Clinical Trial.

3

Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.

Pirwany IR, Sattar N, Greer IA, Packard CJ, Fleming R. Pirwany IR, et al. Among authors: sattar n. Hum Reprod. 2002 Mar;17(3):825-9. doi: 10.1093/humrep/17.3.825. Hum Reprod. 2002. PMID: 11870144

4

A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome.

Kelly CJ, Lyall H, Petrie JR, Gould GW, Connell JM, Rumley A, Lowe GD, Sattar N. Kelly CJ, et al. Among authors: sattar n. J Clin Endocrinol Metab. 2002 Jul;87(7):3287-90. doi: 10.1210/jcem.87.7.8634. J Clin Endocrinol Metab. 2002. PMID: 12107238

5

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.

Harborne L, Fleming R, Lyall H, Sattar N, Norman J. Harborne L, et al. Among authors: sattar n. J Clin Endocrinol Metab. 2003 Sep;88(9):4116-23. doi: 10.1210/jc.2003-030424. J Clin Endocrinol Metab. 2003. PMID: 12970273 Clinical Trial.

6

Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements?

Muth S, Norman J, Sattar N, Fleming R. Muth S, et al. Among authors: sattar n. Hum Reprod. 2004 Dec;19(12):2718-20. doi: 10.1093/humrep/deh530. Epub 2004 Sep 23. Hum Reprod. 2004. PMID: 15388683

7

Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.

Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J, Sattar N, Seifer DB. Fleming R, et al. Among authors: sattar n. Fertil Steril. 2005 Jan;83(1):130-6. doi: 10.1016/j.fertnstert.2004.05.098. Fertil Steril. 2005. PMID: 15652898 Free article. Clinical Trial.

8

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.

Harborne LR, Sattar N, Norman JE, Fleming R. Harborne LR, et al. Among authors: sattar n. J Clin Endocrinol Metab. 2005 Aug;90(8):4593-8. doi: 10.1210/jc.2004-2283. Epub 2005 May 10. J Clin Endocrinol Metab. 2005. PMID: 15886247 Clinical Trial.

9

Does rimonabant pull its weight for type 2 diabetes?

Cleland SJ, Sattar N. Cleland SJ, et al. Among authors: sattar n. Lancet. 2006 Nov 11;368(9548):1632-4. doi: 10.1016/S0140-6736(06)69572-X. Lancet. 2006. PMID: 17098066 No abstract available.

10

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.

Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG. Sattar N, et al. Lancet. 2008 Jun 7;371(9628):1927-35. doi: 10.1016/S0140-6736(08)60602-9. Epub 2008 May 22. Lancet. 2008. PMID: 18501419 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,591 results

Search Page

Filters